AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year - Medical Dialogues

AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year  Medical Dialogues

A four-week supply of Humira, the world's best-selling medicine, has a list price of about $5,174, amounting to more than $60,000 for a year. U.S: AbbVie Inc has ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases